| Literature DB >> 24584117 |
Andreas Schober1, Maliheh Nazari-Jahantigh2, Yuanyuan Wei3, Kiril Bidzhekov4, Felix Gremse5, Jochen Grommes6, Remco T A Megens4, Kathrin Heyll3, Heidi Noels7, Michael Hristov4, Shusheng Wang8, Fabian Kiessling5, Eric N Olson9, Christian Weber10.
Abstract
Atherosclerosis, a hyperlipidemia-induced chronic inflammatory process of the arterial wall, develops preferentially at sites where disturbed laminar flow compromises endothelial cell (EC) function. Here we show that endothelial miR-126-5p maintains a proliferative reserve in ECs through suppression of the Notch1 inhibitor delta-like 1 homolog (Dlk1) and thereby prevents atherosclerotic lesion formation. Endothelial recovery after denudation was impaired in Mir126(-/-) mice because lack of miR-126-5p, but not miR-126-3p, reduced EC proliferation by derepressing Dlk1. At nonpredilection sites, high miR-126-5p levels in endothelial cells confer a proliferative reserve that compensates for the antiproliferative effects of hyperlipidemia, such that atherosclerosis was exacerbated in Mir126(-/-) mice. In contrast, downregulation of miR-126-5p by disturbed flow abrogated EC proliferation at predilection sites in response to hyperlipidemic stress through upregulation of Dlk1 expression. Administration of miR-126-5p rescued EC proliferation at predilection sites and limited atherosclerosis, introducing a potential therapeutic approach.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24584117 PMCID: PMC4398028 DOI: 10.1038/nm.3487
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440